ES2188927T3 - Anticuerpo especifico de staphylococcus aureus y utilizacion del mismo. - Google Patents

Anticuerpo especifico de staphylococcus aureus y utilizacion del mismo.

Info

Publication number
ES2188927T3
ES2188927T3 ES97915542T ES97915542T ES2188927T3 ES 2188927 T3 ES2188927 T3 ES 2188927T3 ES 97915542 T ES97915542 T ES 97915542T ES 97915542 T ES97915542 T ES 97915542T ES 2188927 T3 ES2188927 T3 ES 2188927T3
Authority
ES
Spain
Prior art keywords
staphylococcus aureus
same
specific antibody
strains
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97915542T
Other languages
English (en)
Inventor
Sylviane Merlin
Nicole Battail
Jean-Pierre Flandrois
Gerard Carret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Application granted granted Critical
Publication of ES2188927T3 publication Critical patent/ES2188927T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

ANTICUERPO MONOCLONAL O POLICLONAL ESPECIFICO DE UN EPITOPO COMUN DE LAS CEPAS DE STAPHYLOCOCCUS AUREUS DE DIFERENTES SEROTIPOS CAPSULARES, EN ESPECIAL DE LAS CEPAS RESISTENTES A LAS METICILINAS. EL CITADO ANTICUERPO SE SELECCIONA ENTRE LAS INMUNOGLOBULINAS DE TIPO G, DE TIPO M Y DE TIPO A. ES DE APLICACION EN UN REACTIVO DE DETECCION DE STAPHYLOCOCCUS AUREUS.
ES97915542T 1996-03-21 1997-03-21 Anticuerpo especifico de staphylococcus aureus y utilizacion del mismo. Expired - Lifetime ES2188927T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9603761A FR2746398B1 (fr) 1996-03-21 1996-03-21 Anticorps specifique de staphylococcus aureaus, et utilisations

Publications (1)

Publication Number Publication Date
ES2188927T3 true ES2188927T3 (es) 2003-07-01

Family

ID=9490562

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97915542T Expired - Lifetime ES2188927T3 (es) 1996-03-21 1997-03-21 Anticuerpo especifico de staphylococcus aureus y utilizacion del mismo.

Country Status (10)

Country Link
US (1) US6340571B1 (es)
EP (1) EP0827512B1 (es)
JP (1) JP4213213B2 (es)
AT (1) ATE230760T1 (es)
CA (1) CA2221893C (es)
DE (1) DE69718261T2 (es)
ES (1) ES2188927T3 (es)
FR (1) FR2746398B1 (es)
PT (1) PT827512E (es)
WO (1) WO1997034931A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000071585A1 (en) * 1999-05-03 2000-11-30 Medarex, Inc. Human antibodies to staphylococcus aureus
AU2001236588A1 (en) * 2000-01-31 2001-08-07 The Procter And Gamble Company Antibodies to the staphylococcal multidrug resistance (smr) protein
EP1695086B1 (en) * 2003-12-09 2009-02-18 BioMerieux, Inc. Methods for detecting bacterial pathogens
EP1692512B1 (en) * 2003-12-09 2012-09-05 bioMérieux, Inc. Methods for detecting bacterial pathogens
US7488807B2 (en) * 2006-11-22 2009-02-10 3M Innovative Properties Company Antibody with protein A selectivity
US20100047252A1 (en) * 2006-11-22 2010-02-25 3M Innovative Properties Company Antibody with protein a selectivity
US20110294109A1 (en) * 2008-01-18 2011-12-01 Kinnaird Barbara R Methods for detecting an analyte
DK3903829T3 (da) 2009-02-13 2023-06-26 Immunomedics Inc Immunkonjugater med en intracellulær spaltelig binding
AU2010271116B2 (en) 2009-04-03 2015-08-13 University Of Chicago Compositions and methods related to Protein A (SpA) variants
ES2537437T3 (es) * 2009-05-18 2015-06-08 Julius-Maximilians-Universität Würzburg Anticuerpos o fragmentos de éstos dirigidos contra un epítopo del Staphylococcus aureus de IsaA o IsaB
EP3009455A1 (en) 2009-09-16 2016-04-20 Immunomedics Inc. Class i anti-cea antibodies and uses thereof
IN2012DN03354A (es) 2009-12-02 2015-10-23 Immunomedics Inc
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
EP2704751B1 (en) 2011-05-02 2019-04-17 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
EP2885002A4 (en) 2012-08-14 2016-04-20 Ibc Pharmaceuticals Inc BISPECIFIC ANTIBODIES REDIRECTED AGAINST T CELLS FOR THE TREATMENT OF DISEASES
CA3177936A1 (en) 2012-12-13 2014-06-19 Immunomedics, Inc. Dosages of immunoconjugates of antibodies and sn-38 for improved efficacy and decreased toxicity
CN106132436B (zh) 2014-02-21 2021-06-15 Ibc药品公司 通过诱导对trop-2表达细胞的免疫应答的疾病疗法
US9139649B2 (en) 2014-02-25 2015-09-22 Immunomedics, Inc. Humanized anti-CD22 antibody
US9580495B2 (en) 2014-06-24 2017-02-28 Immunomedics, Inc. Anti-histone therapy for vascular necrosis in severe glomerulonephritis
CN106999517A (zh) 2014-10-07 2017-08-01 免疫医疗公司 抗体‑药物缀合物的新辅助剂用途
EP3286224A4 (en) 2015-04-22 2018-11-14 Immunomedics, Inc. Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
PL3313443T3 (pl) 2015-06-25 2023-11-06 Immunomedics, Inc. Łączenie przeciwciał anty-hla-dr lub anty-trop-2 z inhibitorami mikrotubuli, inhibitorami parp, 5 inhibitorami kinazy brutona lub inhibitorami 3-kinazy fosfoinozytydu istotnie poprawia wynik terapeutyczny nowotworu
SI3316885T1 (sl) 2015-07-01 2021-09-30 Immunomedics, Inc. Imunokonjugati protitelo-SN-38 z linkerjem CL2A
WO2022239720A1 (ja) 2021-05-10 2022-11-17 公益財団法人川崎市産業振興財団 抗原への結合親和性を低減させた抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1231067A (en) * 1983-08-16 1988-01-05 Bioclones (Proprietary) Limited Monoclonal antibody to peroxidase and hybridoma producing it
FR2625321B1 (fr) * 1987-12-24 1992-10-02 Pasteur Institut Reactif pour le diagnostic de staphylococcus aureus par agglutination
US5242824A (en) * 1988-12-22 1993-09-07 Oncogen Monoclonal antibody to human carcinomas
US5069896A (en) * 1989-06-01 1991-12-03 The Gillette Company Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
FR2679923B1 (fr) 1991-08-02 1993-10-22 Bio Merieux Reactif d'identification des bacteries de l'espece staphyloccocus aureus.

Also Published As

Publication number Publication date
FR2746398A1 (fr) 1997-09-26
JPH11506026A (ja) 1999-06-02
CA2221893C (fr) 2011-05-03
PT827512E (pt) 2003-04-30
JP4213213B2 (ja) 2009-01-21
WO1997034931A1 (fr) 1997-09-25
EP0827512B1 (fr) 2003-01-08
DE69718261T2 (de) 2003-09-04
US6340571B1 (en) 2002-01-22
DE69718261D1 (de) 2003-02-13
ATE230760T1 (de) 2003-01-15
EP0827512A1 (fr) 1998-03-11
FR2746398B1 (fr) 1998-04-30
CA2221893A1 (fr) 1997-09-25

Similar Documents

Publication Publication Date Title
ES2188927T3 (es) Anticuerpo especifico de staphylococcus aureus y utilizacion del mismo.
DE69808609D1 (de) Antagonistische anti-avb3 integrin antikörper
NO955167L (no) Monoklonalt anti-V-integrin-antistoff
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
ATE310088T1 (de) Behandlung und nachweis von staphylokokkeninfektionen
DE3885355T2 (de) Monoklonale Antikörper.
AU5809390A (en) Monoclonal antibodies directed against activated microglial cells, hybridomas secreting these monoclonal antibodies, antigen recognized by these monoclonal antibodies and their applications
EP0759943A4 (en) MONOCLONAL ANTIBODIES SPECIFIC TO AN ENDOGLYX-1 ANTIGEN OF VASCULAR ENDOTHELIAL CELLS, THE ANTIGEN ITSELF AND USES THEREOF
BR9702101A (pt) Hibridoma e anticorpo monoclonal
ITMI911767A1 (it) ANTICORPI POLICLONALI ANTI-IRUDINA E LORO UTILIZZO PER LA IDENTIFICAZIONE, LyIMMUNOPURIFICAZIONE E LA DETERMINAZIONE QUANTITATIVA DELLyURIDINA.
ATE118032T1 (de) Monoklonale antikörper und diagnoseverfahren für phytophthora-infektionen.
NO894555L (no) Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet.
DE69020315T2 (de) Monoklonaler antikörper gegen c-reaktives protein.
FR2665061B1 (fr) Passepoil, notamment pour bagage souple.
ITMI910660A0 (it) Anticorpi monoclonali come antidoti
HU9300054D0 (en) Developing elisa test based on monoclonal antibodies to detect infection by m. gallisepticum
HUP0003029A2 (hu) Ankrod specifikus monoklonális antitestek, antitestfragmentumok, keverékeik és alkalmazásuk
ES492111A0 (es) Dispositivo con organos de acoplamiento, fijacion y mando devalvulas de retencion, en especial para recipientes de gas apresion.
FI840949A (fi) Toxiner och antikroppar av mikro- organismen c.difficile.
TH89006B (th) การใช้ แพนตอน-วาเลนไทน์ ลิวโคซิดิน สำหรับการบำบัดและการป้องกันการติดเชื้อสเตปฟีโลคอคคัส
ECSP951605A (es) Fragmentos de anticuerpos monoclonales que tienen actividad inmunosupresora, case ran 4105/171
BR1100555B1 (pt) anticorpos monoclonais humanizados.
FI850484L (fi) Diagnostiskt foerfarande, vid vilket man utnyttjar en ny monoklonal antikropp specifik mot maenniskans t-cellers antigen.
IT1254955B (it) Anticorpi monoclonali murini diretti contro il polisaccaride capsulare di streptococchi di gruppo b di tipo iii